QuantumLead homepage Services

You have accessed back-upped version of our site. Please reffer to new home page for a more up-to-date information.

Quantum Drug hit identification tool

Drug Hit Identification Tool calculates the IC50 (Kd, Ki, pKd) value of any protein-ligand complex, docks a small-molecule in the active site of a protein and performs screening a library of compounds against a target-protein or DNA/RNA. Hit Identification Tool consists of three modules: The IC50 module, 2) Ligand Docking and 3) Library Screening modules. Drug Hit Identification Tool can run both in Windows and Linux environments.

Hit Identification overview brochure IC50 (Kd, Ki, pKd) value calctulation, IC50 Prediction, molecular docking software, new inhibitor, docked ligand, molecular interaction analysis techniques, molecular simulation, Software for protein - ligand IC50 values prediction, receptor based protein ligand flexible docking, computational protein binding assay -Prediction of inhibition- IC50 predictor-activity research

Quantum Receptor Based molecular modeling technology is applicable to any resolved 3D macromolecule structure. You can order our molecular docking and virtual screening services based on molecular structure indicated below or purchase Quantum software to do docking study and other research in-house:


PDB ID: 1JF1

Title: Crystal structure of HLA-A2*0201 in complex with a decameric altered peptide ligand from the MART-1/Melan-A

Functional Class: Immune System

Primary citation: Sliz, P.,Michielin, O.,Cerottini, J.C.,Luescher, I.,Romero, P.,Karplus, M.,Wiley, D.C. Crystal structures of two closely related but antigenically distinct HLA-A2/melanocyte-melanoma tumor-antigen peptide complexes. J.Immunol. v167 pp.3276-3284, 2001

Abstract Title: Crystal structures of two closely related but antigenically distinct HLA-A2/melanocyte-melanoma tumor-antigen peptide complexes.

Keywords: Research, (1jf1:a), (homo, Molecular, Sandwich, Ligand, Immunoglobulins, Presentation, D1jf1a2, D1jf1a1, Peptide, Alpha, Immunoglobulin, (1jf1:b), Alpha-1, Alpha-2, Alpha-3, Antigen, Proteins, 1jf1a2, T-lymphocytes, Activity, Protein, Sapiens, Domain, Binding, Sapiens),, Neoplasm, (1jf1:c), Fragments, Hla-a2.1, Chain, Substances, Water, Antigens, Macromolecular, Class, 1jf1a1, Immunoglobulin-like, U.s., Processing, Proteins, Mart-1/melan-, (antibody, Histocompatibility, Peptide, Beta2-microglobulin, Chain, Homo, Human, Domains, Gov't, X-ray, Amino, Synthetic, Pliability, Melanoma, Support, Receptor, Construct, From, Models, (a+b), Conformation, Antigen,, Beta, Sapiens), Antigen, Decameric, Cytotoxic, 2-layer, Like), Hla-a2, Mainly, Study, Comparative, Crystallography, Constant, Sites, Complex,, Zinc, Protein, Complex, Non-p.h.s., Beta-sandwich, Subunit, Class, Beta-2-microglobulin, Murine, Mhc,, Beta, P.h.s., Class, Major, Antigen-recognition, Domain-, Sequence, Humans, D1jf1b_, 1jf1b0, Histocompatibility, Alpha, Acid, Desriptors, Training set, In silico, Studies, Development, Assessment, Scoring function, Low-frequency normal modes, Degrees of freedom, Geometry refinement (optimization), Investigation, Computation of lowest-frequency modes of, Binding energy prediction, Conformational flexibility, Pharmacophore, Three-dimensional quantitative structure activity relationship methods, Conformational analysis, Profiling, ,


 
Quantum Pharmaceuticals
 

Design by Netrider.ru 2004 (c) Quantum Pharmaceuticals 2004-2008 Computer Aided Drug Design & ADMET